Henry Ford Health

Henry Ford Health Scholarly Commons
Center for Health Policy and Health Services
Research Articles

Center for Health Policy and Health Services
Research

1-5-2021

Comparison of family health history in surveys vs electronic
health record data mapped to the observational medical
outcomes partnership data model in the All of Us Research
Program
Robert M. Cronin
Alese E. Halvorson
Cassie Springer
Xiaoke Feng
Lina Sulieman

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.henryford.com/chphsr_articles

Recommended Citation
Cronin RM, Halvorson AE, Springer C, Feng X, Sulieman L, Loperena-Cortes R, Mayo K, Carroll RJ, Chen Q,
Ahmedani BK, Karnes J, Korf B, O'Donnell CJ, Qian J, and Ramirez AH. Comparison of family health
history in surveys vs electronic health record data mapped to the observational medical outcomes
partnership data model in the All of Us Research Program. J Am Med Inform Assoc 2021.

This Article is brought to you for free and open access by the Center for Health Policy and Health Services
Research at Henry Ford Health Scholarly Commons. It has been accepted for inclusion in Center for Health Policy
and Health Services Research Articles by an authorized administrator of Henry Ford Health Scholarly Commons.

Authors
Robert M. Cronin, Alese E. Halvorson, Cassie Springer, Xiaoke Feng, Lina Sulieman, Roxana LoperenaCortes, Kelsey Mayo, Robert J. Carroll, Qingxia Chen, Brian K. Ahmedani, Jason Karnes, Bruce Korf,
Christopher J O'Donnell, Jun Qian, and Andrea H. Ramirez

This article is available at Henry Ford Health Scholarly Commons: https://scholarlycommons.henryford.com/
chphsr_articles/225

Journal of the American Medical Informatics Association, 00(0), 2020, 1–9
doi: 10.1093/jamia/ocaa315
Research and Applications

Downloaded from https://academic.oup.com/jamia/advance-article/doi/10.1093/jamia/ocaa315/6065964 by guest on 24 February 2021
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ABSTRACT
Objective: Family health history is important to clinical care and precision medicine. Prior studies show gaps in data
collected from patient surveys and electronic health records (EHRs). The All of Us Research Program collects family history from participants via surveys and EHRs. This Demonstration Project aims to evaluate availability of family health
history information within the publicly available data from All of Us and to characterize the data from both sources.
Materials and Methods: Surveys were completed by participants on an electronic portal. EHR data was mapped
to the Observational Medical Outcomes Partnership data model. We used descriptive statistics to perform exploratory analysis of the data, including evaluating a list of medically actionable genetic disorders. We performed a subanalysis on participants who had both survey and EHR data.
Results: There were 54 872 participants with family history data. Of those, 26% had EHR data only, 63% had survey only, and 10.5% had data from both sources. There were 35 217 participants with reported family history of
a medically actionable genetic disorder (9% from EHR only, 89% from surveys, and 2% from both). In the subanalysis, we found inconsistencies between the surveys and EHRs. More details came from surveys. When both
mentioned a similar disease, the source of truth was unclear.
Conclusions: Compiling data from both surveys and EHR can provide a more comprehensive source for family
health history, but informatics challenges and opportunities exist. Access to more complete understanding of a
person’s family health history may provide opportunities for precision medicine.
Key words: Family health history, precision medicine, health surveys, electronic health records
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INTRODUCTION

MATERIALS AND METHODS
We analyzed data from the September 2019 All of Us registered tier
version R2019Q4R3. This dataset included family health history
surveys administered to participants between May 2018 and September 30, 2019, as well as EHR data between 1980 and 2019. For
the purposes of this project, an observation is the mention of the
presence or absence of a family history of a certain disease. Each
participant can have multiple family history observations, as they
may have more than 1 family health history condition in more than
1 relative. We analyzed data at both the participant and observation
levels.

Surveys
All of Us collects survey data through a participant portal which can
be accessed through the Internet on a desktop computer, or via a
downloadable app on a tablet or smartphone. The development and
launch of these surveys are described elsewhere.13 There are 6 surveys: the first 3 are available when a participant enrolls, and the
remaining surveys, including family health history, become available
90 days after initial enrollment.
Participants are asked questions about the health history of
first-degree blood relatives, including mother, father, siblings, and
children, as well as grandparents (Supplementary Appendix 1).
Each response to a question that refers to a disease is considered
an independent observation of family health history from the survey. Diseases are grouped by categories that cover most organ systems, including heart, lung, gastrointestinal, and endocrine. A
participant may skip questions or respond “prefer not to answer”
or “don’t know,” as well as “no blood-related siblings” and “no
blood-related children.” The full survey is located online (https://
www.researchallofus.org/data-sources/survey-explorer/). We excluded survey participants who indicated that they did not know
any family health history and those who skipped every question.
The family health history survey was designed to focus on medically actionable genetic disorders, guided by the list of genes/disorders recommended by the American College of Medical Genetics
and Genomics for reporting secondary findings from genome sequencing.14 Therefore, all diseases have a corresponding question
for each relative and can be mapped from the survey to the disease
in a structured manner (ie, a participant can select any of the
diseases in the list for each relative in the family health history
survey).

Electronic health records
EHR data about family health history were mapped to OMOP using
Systematized Nomenclature of Medicine (SNOMED) and International Classification of Diseases codes. These vocabularies contain
medical condition codes for family history as well as codes for relatives with a family history; however, there are no singular codes that
link a medical condition code to a specific relative. Data from each
healthcare organization’s EHR are sent to a data repository at the
Data Research Center for All of Us.
In this project, we identified family health history information in
EHR data by reviewing the OMOP hierarchy for records with
“familyþhistory” or “FH:” anywhere in their OMOP concept
name. We subsequently looked at parent concepts to identify any
additional concepts that could be included. There were 235 unique
OMOP concept names that satisfied these criteria (Supplementary
Appendix 2). We excluded observations of “family social history”
because family social history is related to a social situation like the
death or absence of a family member and is not considered a medical
condition. We also removed duplicate observation and value concepts from the same healthcare organization regarding the same par-
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Family health history is long recognized to be important in clinical
care and precision medicine.1–3 Through family history, healthcare
providers can recognize the potential risk of disease in an individual
based on inheritance. By understanding an individual’s disease risk,
early interventions can help mitigate or prevent familial disease occurrence. Harnessing informatics tools like predictive modeling and
machine learning models can significantly improve the precise care
that we deliver to patients.
Prior studies show gaps in data from electronic health record
(EHR) structured fields that are moderately assisted by free text extraction; however, there are significant limitations in routine acquisition of family health history from EHRs.4–6 Family health history
can also be collected through patient surveys. Patient surveys or
questionnaires show promise in obtaining family history.3,7,8 However, similar to EHRs, patient surveys may collect limited data.7
While both EHRs and patient surveys could have more complete
family health history, single-center studies combining data sources
demonstrate limitations.9,10 There is a paucity of literature describing a publicly available using both data sources to describe family
history of a large diverse cohort across the United States.
The All of Us Research Program (All of Us) is recruiting 1 million or more participants reflecting the rich diversity of the U.S. population to advance the science of precision medicine (https://www.
researchallofus.org/).11 All of Us is collecting unique family health
history information using online surveys and EHR data from participants recruited at multiple healthcare organizations across the country. Both data types are mapped to the Observational Medical
Outcomes Partnership (OMOP) common data model (https://
github.com/OHDSI/CommonDataModel/wiki). These data are then
curated with algorithms to develop a clean dataset, followed by privacy rules to ensure participant de-identification. Additionally,
fields containing identifiable information are removed. Curated data
are deposited into the All of Us Researcher Workbench, a cloudbased analytic platform for researchers which includes custom
graphical interface data selection tools and client support for Python
or R in Jupyter notebooks. All of Us developed a set of Demonstration Projects to highlight the ability of the initial launch data and
tools to answer pertinent research questions as well as address limitations of the data.12 This Demonstration Project aims to evaluate
the availability of family health history information within the All of
Us registered tier data and to characterize the structured data elements from both data sources.

The All of Us Research Program Institutional Review Board has
established that registered tier data available on the Researcher
Workbench (https://workbench.researchallofus.org/) meet criteria
for non–human subjects research. Therefore, this demonstration
project did not require Institutional Review Board review.
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Table 1. Classifications of family history based on the positive or negative family history, a specified disease, and a specified relative
Class
Positive
1
2
3

Positive family history with a specified disease
in specified relative
Positive family history with a specified disease
in unspecified relative
Positive family history with an unspecified disease in specified relative
Positive family history with an unspecified disease in unspecified relative

Negative
5
Negative family history with a specified disease
in specified relative
6
Negative family history with a specified disease
in unspecified relative
7
Negative family history with an unspecified disease in specified relative
8
Negative family history with an unspecified disease in unspecified relative
Other
9
Other

Survey Data

EHR Observation Data

Responses to subquestions about relative
conditions
NA

Observation with relative þ disease pair
in a single row to confirm a match
EHR observations with family history
disease concepts
Observations with family history relative
concepts

Responses of “Other,” “Other cancer,”
or “Other/unknown diabetes” to the
subquestions about relative conditions
NA

Observations with “Family history of disorder” or ”Family history of clinical
finding” concepts

NA

NA

NA

Observations with “No family history of
disease” concepts
Observations with “Relative alive and
well” concepts
Observations with “No family history
of” concepts

Responses of “None of the above” at the
relative condition parent-question level
NA

Responses of “Skip”/”Prefer not to
answer”/”Don’t know”/”Not related
by blood” at the relative condition parent-question level

EHR observations with “Family history
with explicit context”

EHR: electronic health record; NA: not applicable; UBR: underrepresented in biomedical research.

ticipant. When searching for the hereditary diseases from a list of
medically actionable genetic disorders as described previously, we
manually reviewed all 235 OMOP concepts to identify codes
that would specify these diseases (Supplementary Appendix 3).
Additionally, we attempted to systematically link EHR family history information to specific diseases using the OMOP relations table, which maps EHR conditions or SNOMED concepts to family
health history survey concepts (Supplementary Appendix 4). Each
survey response is mapped to a SNOMED code using the “Maps
to value” relationship; however, it is not identified as a family history code. Hence, we mapped the identified history concept to a
set of history codes using the “Asso finding of” relationship. For
instance, the “Daughter Cancer Condition: Lung Cancer” survey
response has a “Maps to value” relationship with Malignant tumor of lung” which can be linked to “Family history of malignant
neoplasm of lung” using the “Asso finding of” relationship. Using
this approach of OMOP mapping, we mapped 9 of the 11
medically actionable genetic disorders to EHR family history
conditions.

Statistical analysis
To compare family health history from surveys and EHRs, each survey question response or OMOP concept code was considered an
observation. Each observation describes a positive or negative family history and may or may not have an associated relative or disease. A complete observation will ideally have a known family
history of a specified disease for a certain relative. However, owing
to the varying methods used by healthcare organizations when submitting OMOP mapped EHR data to All of Us, some information
required for a complete family history may be missing. The struc-

tured nature of the family health history survey yields mostly complete observations, although the survey does not ask participants
about negative family history of a specific disease. Therefore, all
observations were assigned a category depending on the type of information present (Table 1). For example, there may be a positive
family history or negative family history. The disease may be specified or not, meaning that the positive or negative family history is
about a specific disease, such as breast cancer. Finally, a relative
may be specified, such as family history in a mother. Either the disease or relative may not be specified leading to the categories in
Table 1. To evaluate data types and information in the All of Us
Research Program, we used descriptive statistics to (1) describe
what kind of and how much information was present in the survey
and EHR data, as categorized in Table 1; and (2) explore the presence of a family history of 11 diseases in the list adapted from American College of Medical Genetics and Genomics published
recommendations. The descriptive statistics included frequencies
and percentages of categorical data (eg, number of observations
with any family history data in surveys, EHRs, or both, and observations of family history of specific diseases, such as certain cancers,
heart failure, myocardial infarction, or liver disease). Two authors
(A.E.H., R.M.C.) reviewed data from 10 participants to explore the
overlap between the survey and EHR data.

RESULTS
General findings
There were 224 143 participants in the registered tier version of the
All of Us database. Of the total participants, any EHR observation
data were available in 126 252 participants. Family history–related
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specific observations were available for 20 135 participants from 21
different healthcare organizations. The number of unique family history EHR observations per participant ranged from 1 to 16 (median
of 1). Among the 224 143 All of Us participants who answered at
least 1 question on any survey, 40 492 participants from more than
41 states completed the family health history survey (Figure 1). The
number of conditions reported in survey responses ranged from 1 to
172 (median of 13). Using both data sources, there were 54 872 participants with 695 127 unique observations of any family history
data. Of the total participants, 26% had family history observations
from EHR only, 63% had survey observations only, and 11% had
both survey and EHR observations (Figure 2). The percentage of
family history data available stratified by participant-level variables
including those classified as underrepresented in biomedical research, defined elsewhere (Supplementary Appendix 5),15 is represented in Table 2. The overall proportions of observations included
in each family history category from Table 1 are summarized in
Figure 3.

Survey classifications
There were a total of 658 034 family health history survey data
observations (this is the denominator for the percentages reported in
this section). Positive family history of a specific disease made up
87.1% observations, 3.8% identified negative family history, and
9% comprised other responses.
Positive family history
Most observations had a positive history (presence) of a disease with
a relative named (Table 1, class 1: 84.9%). Owing to the structured
nature of the All of Us survey data, this is the most common classification (eg, a daughter with type 1 diabetes). A small number had
only a relative named without a disease (class 3: 2.2%). Observations from this class were from survey questions that required free

Figure 2. Venn diagram showing the number of participants with electronic
health record (EHR), survey, or overlap from both sources of any family history data out of the total number of participants with any family history data
(N ¼ 54 872).

text responses (eg, daughter with other cancer, please specify). Owing to the complexity of mapping free text fields to OMOP as well
as the All of Us privacy rules for the public dataset that remove all
free text fields, we are unable to extract the presence of a specific
disease from these responses.

Negative family history
A small percentage of observations had a negative (absent) family
history of a disease with a named a relative (Table 1, class 7: 3.8%).
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Figure 1. Number of participants in the All of Us cohort with family history data available from electronic health record (EHR) (left) and surveys (right). The largest
circle describes the total number of participants in the cohort, the middle circle (left) describes participants having any EHR data, and the smallest circle describes
the participants with family history EHR data (left) or survey family history data (right).
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Table 2. Percentage of family health history information for participant-level variables including UBR as defined by the All Of Us Research
Program

Participant-Level Variable

Entire All of
Total EHR or
EHR-Only
Survey-Only
Overlap
Us Cohort
Survey Participants Participants
Participants
Participants
(n ¼ 224 143) (%) (n ¼ 54 872) (%) (n ¼ 14 380) (%)(n ¼ 34 737) (%)(n ¼ 5755) (%)

41
26
14
7
5
4
3

53
20
13
6
5
2
1

45
20
17
5
8
3
2

55
21
11
6
4
1
1

61
15
12
4
6
1
1

91
7
2

97
2
1

95
3
2

97
2
1

98
1
1

46
51
3

51
48
1

42
56
2

55
44
1

51
48
1

77
48
26
13
1
3

66
26
35
11
1
2

78
42
37
11
1
3

61
21
33
12
1
2

16
16
43
8
1
2

12

10

9

11

7

28
10

16
3

28
8

11
1

11
1

EHR: electronic health record; UBR: underrepresented in biomedical research.

A total of 35 997 family history observations were from EHR data
(this is the denominator for the percentages reported in this section).
Positive family history made up 95.8% of the observations, 4.2%
had negative family history data, and 20 or fewer observations were
classified as “other.”

came from classes 2 and 3, indicating only a disease code or relative
code without linkage. For example, sites will send a single observation disease and a separate observation for relative specification,
without linking participant’s rows (Supplementary Appendix 8). In
this example, a similar family history entry appeared on 2 separate
dates (February 3, 2018, and February 20, 2018), and each date
includes 2 codes. Of the 2 codes, one describes a family history of a
disease (coronary arteriosclerosis) and the other identifies a relative
(father). However, the disease and relative are not linked, so we cannot confirm that this combination refers to a father with coronary
arteriosclerosis. There likely is a valid link in this case because there
is only 1 disease and 1 relative present; however, linking multiple
diseases and multiple relatives remains difficult. A smaller number
of observations (class 4: 35.2%) identified the presence of family
history, but without a disease or a relative. These concepts were
“Family history of disorder” or “Family history of clinical finding.”
While these data suggest that there is a family history of a condition,
the specifics are unclear.

Positive family history
Only 1.3% (Table 1, class 1) of the family history EHR observations
had both a relative and disease named. This was concluded via a
row-level link in the OMOP observation table between a relativespecific family history code as an observation concept and a family
history of disease code as a value concept. Most codes (59.3%)

Negative family history
A small number of observations had a negative family history of a
specified disease without a relative (Table 1, class 6: 1.4%). These
cases included the concept code “no family history” of a disease
(Supplementary Appendix 9). Very few observations had a negative
family history of a relative without a disease (class 7: 1.2%). These

In the survey, there is an option to select “none of the above” for all
diseases in a specific relative (Supplementary Appendix 6). This is
similar to responding that relative is alive and healthy.
Other
The “Other” category constituted answers submitted by participants
that did not give a positive or negative family history. This 9% of
observations which included the response options of “no siblings or
children related by blood,” “don’t know,” or “prefer not to answer”
(Supplementary Appendices 6 and 7).

EHR classifications
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Marital status
Married
Never married
Divorced
Living with partner
Widowed
Separated
No answer
Health insurance status
Yes
No
Don’t know/No answer
Employment status
Employed/self-employed
Not employed
No answer
UBR category (UBR definition)
Overall (met at least 1 UBR criterion)
Race/ethnicity (responses other than White or Hispanic/Latino)
Age 65 y
Sexual/gender minority
Sex at birth (not male or female)
Gender identity
(neither man nor woman, or
different than sex at birth)
Sexual orientation
(responses other than straight)
Income <$25 000
Education (< GED)
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concepts described family members that were alive and well (eg,
“FH: Mother alive and well”). Finally, a negative history without a
disease or relative was rarely observed (class 8: 1.7%). These were
observations with a “No family history of” concept.
Other
Only 20 or fewer observations belonged to the other category, defined as having a concept of “Family history with explicit context”
or “Other specified conditions influencing health status.” These
codes are unclear if they signify a family history of a disorder.

Overlap between survey and EHR data
Of the 54 872 All of Us participants, 10.5% had overlapping family
health history information from surveys and EHRs. To evaluate this
overlap, we (1) conducted a closer examination of 10 random participants with overlapping family history observations (Supplementary Appendix 10), and (2) reviewed overlap of actionable medical
disorders as presented in the next section. In all 10 cases, EHR and
survey data were inconsistent, and each source provided more family health information than the other depending on the participant.
Details about each participant are included in Supplementary Appendices 10 and 11.

Actionable medical disorders
There were 35 217 participants (86 054 observations) with a family
history of diseases from the list of actionable medical disorders (Table 3). A family history of heart attack/myocardial infarction was
the most reported (18 859 participants), followed by breast cancer

(12 733 participants). All other diseases were reported by fewer
than 10 000 participants. Breast cancer had the most overlap of survey and EHR data (6.2%), with all other diseases having 2% or less
overlap (Table 3). EHRs contributed the most data in breast cancer
(29.8% EHR only), followed by heart attack/myocardial infarction
(8.7%), kidney cancer (5.7%), and colorectal cancer (3.2%). All
other diseases had <1% of the information coming from EHR
alone. Except for breast cancer, surveys contributed about 90% or
more of the data, with congestive heart failure being almost exclusively seen in survey data.

DISCUSSION
This Demonstration Project describes and compares family health
history data in surveys and EHRs mapped to OMOP from the All of
Us Research Program. We discovered a large population of participants with data sourced from surveys or EHRs. There have been
other registries with large populations of family health history, but
they tend to focus on a specific disease or set of diseases and are usually from a single data source (eg, surveys or EHRs).16–18 Large genetic databases like the U.K. Biobank19 and Million Veterans
Program20 collect multiple data sources including genetic information. A recent study from the UK Biobank demonstrated that selfreported family history can be limited without genetics.21
However, this UK Biobank study did not report on EHR data. Our
demonstration project in All of Us works with a significant amount
of data from both surveys and EHRs and provides an examination
of diseases with effective interventions. However, like other studies,4–7,9,10 we discovered substantial gaps in data collected from the
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Figure 3. Distribution of family history observations in survey and electronic health record (EHR) data stratified by positive or negative family history, presence or
absence of disease, and presence or absence of a relative in the observation. The total number of survey observations was 658 034 and the total number of EHR
observations was 35 997. Percentages of surveys and EHRs are based on the total numbers of observations, respectively.
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Table 3. Medically actionable genetic disorders from a list of genes and disorders for reporting secondary findings from genome sequencing

Disease

EHR-Only
Participants
(n ¼ 14 380)

Survey-Only
Participants
(n ¼ 34 737)

Overlap
Participants
(n ¼ 5755)

Relative Ratio of Disease
Discovery (EHR vs Survey)

12 733
6753
6171
2033
1160
1191
1955
2436
9559
9012
18 859

3795 (29.8)a
28 (0.4)
198 (3.2)
20 or fewerb
20 or fewerb
68 (5.7)
20 or fewerb
20 or fewerb
59 (0.6)
20 or fewerb
1649 (8.7)

8144 (64.0)a
6705 (99.3)
5893 (95.5)
1993 (98.0)
1120 (96.6)
1103 (92.6)
1915 (98.0)
2396 (98.3)
9480 (99.2)
8972 (100)
16 841 (89.3)

794 (6.2)a
20 (0.3)
80 (1.3)
20 or fewerb
20 or fewerb
20 or fewerb
20 or fewerb
20 or fewerb
20 or fewerb
20 or fewerb
369 (2.0)

1.033
0.014
0.094
0.04
0.071
0.158
0.042
0.033
0.017
0.009
0.236

Values are n (%). The percentages for each row are calculated by the total participants in each row (eg, 3795 is 29.8% of 12 733). Relative ratio of disease discovery controls the unbalanced number of participants in the EHR and survey, and is defined as:

PðEHR & Disease þ jEHRÞ
:
PðSurvey & Disease þ jSurveyÞ
Which is equivalent to:
ð participants in the EHR and DiseaseþÞ
participants in EHR
:
participants in the survey and Diseaseþ
participants in the survey
3795þ794

For breast cancer, this is 14380þ5755
8144þ794 ¼ 1.033. A relative risk > 1 means that the EHR contains more disease information; a relative risk < 1 means that the survey
34737þ5755
contains more disease information.
EHR: electronic health record; UBR: underrepresented in biomedical research.
a
Distributions of data source contributions (EHR, survey, both) similar to the distribution of the entire cohort.
b
According to All of Us publication policy, all counts of participants in publications that are less than 20 should be generalized to the phrase “20 or fewer.”

EHR and surveys. There are many important reasons for these gaps.
Mapping of EHR data to a structured common data model (eg,
OMOP) can lead to a loss of information because of an inability to
obtain unstructured data from the EHR or difficulty transforming
structured data to the common data model,22,23 such as error or
omission of family history data due to participants forgetting information or not being aware of the information, or healthcare providers not obtaining or documenting the information. Finally, a lack
of an ability to enter data, such as limiting the number of questions
on a survey or what structured data can be entered on a specific
EHR system, can cause these gaps. There were also interesting findings in the overlap of survey and EHR data. Despite limitations, our
findings suggest that multiple data sources may provide more accurate family health history information than a single source alone.
Interesting insights surfaced from the examination of overlapping survey and EHR data. On the one hand, in many cases, more
family history was available in the survey responses as compared
with the EHR. The structured nature of the survey offers an opportunity for a more systematic collection of family history of specific
diseases on relatives. On the other hand, diseases in EHRs were
sometimes missing from the survey records. This discrepancy ultimately creates uncertainty in determining the gold standard for family health history information. In 1 case, a participant had
responded that their father had a heart attack in the family health
history survey (Supplementary Appendix 12), but their EHR noted
that their father had coronary artery disease. Reasons for discrepancies between EHR and survey data could include (1) a chronological

gap between when the participant answered the survey question and
when the EHR data were entered (eg, a father may have had coronary artery disease at the time of the survey and later had a heart attack), (2) the ability of the participant to remember or understand
the father’s disease, or (3) a data entry error by either the healthcare
provider or the participant. Resolving these sources of discrepant information are areas for future research. Additional data sources can
provide important complementary information. All of Us is collecting DNA for future genetic analyses. A comprehensive examination
of the genome for pathogenic or likely pathogenic gene variants or
polygenic risk scores in participants who report a family history
may complement data from the patient surveys and EHR. Additionally, answers to questions such as “what percent of individuals
reporting or not reporting family history of breast cancer have a mutation promoting breast cancer?” could be explored.
Medically actionable diseases also had discrepancies between the
EHRs and surveys. History of breast cancer was present in more relatives in the EHR data than surveys because the family health history survey does not ask about distant relatives. Information about a
participant’s family history of gastric cancer was present in the survey but not in the EHR, possibly owing to issues with specificity of
what is in the EHR data or mapping of raw data to the OMOP format (eg, neoplasm of digestive organ). Therefore, ensuring that data
in the EHR have the appropriate specificity of the disorder (eg, gastric cancer and not neoplasm of digestive organism) as well as improving mapping to OMOP can help. There was almost no overlap
between surveys and EHR in the liver disease category (fewer than
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Breast cancer
Lung cancer
Colorectal cancer
Stomach cancer
Thyroid cancer
Kidney cancer
Brain cancer
Liver disease
Coronary artery disease
Congestive heart failure
Heart attack/myocardial infarction

Total EHR or
Survey Participants
(n ¼ 54 872)
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additional family history data (eg, additional OMOP codes) and
data types not included in the current analysis.
The Demonstration Projects led by All of Us aims to describe the
utility of family health history data available to researchers at the
beta launch of the Researcher Workbench. All analyses shown here
are available to registered users of the Researcher Workbench for
replication and reuse to support hypothesis generation and discovery
by the broader research community.

CONCLUSION
This description of the family health history data in the All of Us
registered tier database will assist future investigators in understanding All of Us data methods and provide feedback to the program on
the utility of participant surveys and EHR data. In this Demonstration Project, we demonstrated the potential informatics challenges
and opportunities for biomedical research of family history data
from different sources, which were mapped to a common data
model in an attempt to identify a common source of truth regarding
family history in a large, diverse cohort of participants across the
United States.

FUNDING
The All of Us Research Program is supported (or funded) by grants
through the National Institutes of Health Office of the Director: Regional Medical Centers (1 OT2 OD026549, 1 OT2 OD026554, 1
OT2 OD026557, 1 OT2 OD026556, 1 OT2 OD026550, 1 OT2
OD 026552; 1 OT2 OD026553, 1 OT2 OD026548, 1 OT2
OD026551, 1 OT2 OD026555, IAA #: AOD 1603); Federally
Qualified Health Centers (HHSN 263201600085U), Data and Research Center (5 U2C OD023196), Biobank (1 U24 OD023121),
the Participant Center (U24 OD023176), Participant Technology
Systems Center (1 U24 OD023163), Communications and Engagement (3 OT2 OD023205, 3 OT2 OD023206), and Community
Partners (1 OT2 OD025277, 3 OT2 OD025315, 1 OT2
OD025337, 1 OT2 OD025276). In addition to the funded partners,
the All of Us Research Program would not be possible without the
contributions made by its participants. RMC was supported by the
National Heart, Lung, and Blood Institute of the National Institutes
of Health under Award Number K23HL141447. JHK is supported
by the National Institutes of Health Office of the Director
(1OT2OD026549) and the National Heart, Lung, And Blood Institute of the NIH (K01HL143137).

AUTHOR CONTRIBUTIONS
RMC, RJC, CJO, AHR conceived the study design. All authors contributed to data collection. RMC, AEH, XF, QC performed data
analysis and interpretation of the results. All authors contributed to
the writing and review of the manuscript.

SUPPLEMENTARY MATERIAL
Supplementary material is available at Journal of the American
Medical Informatics Association online.

Downloaded from https://academic.oup.com/jamia/advance-article/doi/10.1093/jamia/ocaa315/6065964 by guest on 24 February 2021

20). The survey asks about a family history of liver disease, but
again EHR data may not have been mapped to an OMOP concept
like cirrhosis or liver disease because it is located in unstructured
data or not typically captured. Generally, survey data had more extensive family history. In 1 participant’s family history of thyroid
cancer, the EHR had only 1 mention of thyroid cancer for a specified relative, whereas the survey had 3 relatives with thyroid cancer.
Owing to the lack of disease-relative linkage guidelines in the mapping of EHR data to OMOP, the surveys had more specific family
history information. When considering certain mutations such as
BRCA in analyzing the family history of breast cancer, more specific
family history will be important.24 The finding that most medically
actionable genetic disorders were in the surveys but not EHRs
emphasizes the importance of properly capturing and mapping family history to common data models.
Data quality of family history within All of Us has important
limitations and considerations. First, we do not have access to free
text from the EHR or free text answers in the survey due to privacy
rules in the registered tier to prevent reidentification of participants. Future directions to utilize natural language processing and
map to OMOP could enable these data to be used. Second, limitations within EHR-specific family health history included a lack of
linkage between diseases, relatives, and duplicates. Only a few
sites sent linked OMOP codes between diseases and relatives. This
could be related to the way the information is stored in their EHR
or the lack of awareness that diseases and relatives could be transmitted to the data repository as a linked set. Improving the standard way in which these data are collected, transmitted, and
stored for All of Us researchers could allow for more extensive
analyses. Also, using a different standard like the Fast Healthcare
Interoperability Resources could lead to different results. Third,
the response rate of the family health history survey is low, and the
All of Us Research Program is engaged in a campaign to increase
completion rates of surveys from nonrespondents through phone
calls and postal mailings. Response rates in surveys were particularly low in certain underrepresented in biomedical research populations such as lower education. Statistical weighting methods,
such as inverse probability weighting, multiple imputation, or a
combination of the 2, could be useful when trying to adjust for
nonresponders.25 In addition, there may be other confounders limiting survey data, such as digital literacy, availability of stable Internet connections, or smartphones. These limitations should be
considered by researchers using these data. Fourth, we assume that
responses from surveys and EHR family history data are from
blood relatives; however, participants may respond about adoptive
relatives. Fifth, there were a significant number of duplicates in the
EHR data. These duplicates may be true duplicates or could be additional family history. This distinction was difficult to determine
given the limited row-level linkages between EHR diseases and relatives. True duplicates are potentially attributable to data being
recorded in the EHR systems used to populate the OMOP instance
at a 1-row-per-contact basis. Therefore, every time the participant
completes a family history form or every time a provider reviews
the family history data, another row could be populated in the
EHR source data, and thus mapped into OMOP and sent to the
data repository. Sixth, including a survey with all possible diseases
and relatives may give more data but increases participant burden.
Survey responses are also susceptible to misclassification and multiple biases. Last, these results are specific to the release of the registered tier in September 2019; future releases may include
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De-identified data are available on the researcher workbench of the
All of Us Research Program located at https://workbench.researchallofus.org.
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